160 related articles for article (PubMed ID: 36891703)
1. [Inhibition of receptor-interacting protein 3 improves experimental autoimmune hepatitis].
Liu M; Zhang HX; Zhang L; Zhao JW; Zhou L; Wang BM
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1231-1236. PubMed ID: 36891703
[No Abstract] [Full Text] [Related]
2. RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism.
Liu M; Zhang H; Zhang L; Liu X; Zhou S; Wang X; Zhong W; Zhang J; Wang B; Zhao J; Zhou L
Int J Biol Sci; 2022; 18(1):199-213. PubMed ID: 34975327
[TBL] [Abstract][Full Text] [Related]
3. Multi-Omics Analysis Reveals the Protection of Gasdermin D in Concanavalin A-Induced Autoimmune Hepatitis.
Wang K; Wu W; Jiang X; Xia J; Lv L; Li S; Zhuge A; Wu Z; Wang Q; Wang S; Li L
Microbiol Spectr; 2022 Oct; 10(5):e0171722. PubMed ID: 35972273
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models.
Ye T; Wang T; Yang X; Fan X; Wen M; Shen Y; Xi X; Men R; Yang L
Cell Physiol Biochem; 2018; 46(3):1241-1251. PubMed ID: 29672295
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation.
Xia G; Wu S; Wang X; Fu M
Can J Physiol Pharmacol; 2018 Dec; 96(12):1293-1300. PubMed ID: 30290123
[TBL] [Abstract][Full Text] [Related]
6. NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis.
Luan J; Zhang X; Wang S; Li Y; Fan J; Chen W; Zai W; Wang S; Wang Y; Chen M; Meng G; Ju D
Front Immunol; 2018; 9():758. PubMed ID: 29692782
[TBL] [Abstract][Full Text] [Related]
7. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
Liu M; Li H; Yang R; Ji D; Xia X
J Neuroinflammation; 2022 Oct; 19(1):262. PubMed ID: 36289519
[TBL] [Abstract][Full Text] [Related]
8. Receptor-interacting protein kinase 3 mediates macrophage/monocyte activation in autoimmune hepatitis and regulates interleukin-6 production.
Zhang J; Guo L; Liu M; Jing Y; Zhou S; Li H; Li Y; Zhao J; Zhao X; Karunaratna N; Jiang K; Zhou L; Wang B
United European Gastroenterol J; 2018 Jun; 6(5):719-728. PubMed ID: 30083334
[TBL] [Abstract][Full Text] [Related]
9. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages
Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B
Front Immunol; 2021; 12():624360. PubMed ID: 33841405
[TBL] [Abstract][Full Text] [Related]
10. Oroxylin A inhibited autoimmune hepatitis-induced liver injury and shifted Treg/Th17 balance to Treg differentiation.
Zhu J; Chen H; Cui J; Zhang X; Liu G
Exp Anim; 2023 Aug; 72(3):367-378. PubMed ID: 36927981
[TBL] [Abstract][Full Text] [Related]
11. Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6/STAT3-interleukin-17 signaling.
Li D; Chen J; Lin B; Guo Y; Pan J; Yu C; Wan X
J Gastroenterol Hepatol; 2023 May; 38(5):821-829. PubMed ID: 36967570
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
Huang H; Deng Z
Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
[TBL] [Abstract][Full Text] [Related]
13. [Preventive and therapeutic effects of rapamycin against autoimmune hepatitis and liver fibrosis and possible mechanisms].
Li WW; Sun P; Chen DD; Wang WQ; Jiao GH; Wang YJ; Zhou L; Wang BM; Zhang J
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):368-74. PubMed ID: 27470891
[TBL] [Abstract][Full Text] [Related]
14. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Hegde VL; Nagarkatti PS; Nagarkatti M
PLoS One; 2011 Apr; 6(4):e18281. PubMed ID: 21483776
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury.
Deutsch M; Graffeo CS; Rokosh R; Pansari M; Ochi A; Levie EM; Van Heerden E; Tippens DM; Greco S; Barilla R; Tomkötter L; Zambirinis CP; Avanzi N; Gulati R; Pachter HL; Torres-Hernandez A; Eisenthal A; Daley D; Miller G
Cell Death Dis; 2015 May; 6(5):e1759. PubMed ID: 25950489
[TBL] [Abstract][Full Text] [Related]
16. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.
Erhardt A; Biburger M; Papadopoulos T; Tiegs G
Hepatology; 2007 Feb; 45(2):475-85. PubMed ID: 17256743
[TBL] [Abstract][Full Text] [Related]
17. sFgl2 gene-modified MSCs regulate the differentiation of CD4
Ji W; Wang W; Li P; Liu Y; Zhang B; Qi F
Stem Cell Res Ther; 2023 Nov; 14(1):316. PubMed ID: 37924141
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis.
Longhi MS; Liberal R; Holder B; Robson SC; Ma Y; Mieli-Vergani G; Vergani D
Gastroenterology; 2012 Jun; 142(7):1526-35.e6. PubMed ID: 22387392
[TBL] [Abstract][Full Text] [Related]
19. MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitis.
Zhang G; Wu S; Xia G
Ann Hepatol; 2024; 29(2):101183. PubMed ID: 38043702
[TBL] [Abstract][Full Text] [Related]
20. PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury.
He GW; Günther C; Kremer AE; Thonn V; Amann K; Poremba C; Neurath MF; Wirtz S; Becker C
Gut; 2017 Apr; 66(4):716-723. PubMed ID: 27566130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
